Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2016 1
2017 2
2018 5
2019 2
2020 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
L’immunothérapie dans les cancers ORL.
Reverdy T, Gau M, Karabajakian A, Neidhardt EM, Fayette J. Reverdy T, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S35-S42. doi: 10.1016/S0007-4551(18)30388-6. Bull Cancer. 2018. PMID: 30595197 Review. French.
Nivolumab in recurrent/metastatic head and neck cancers.
Karabajakian A, Reverdy T, Gau M, Fayette J. Karabajakian A, et al. Among authors: reverdy t. Future Oncol. 2018 Mar;14(7):603-609. doi: 10.2217/fon-2017-0440. Epub 2017 Nov 13. Future Oncol. 2018. PMID: 29130342
Methods and Designs of Modern Breast Cancer Confirmatory Trials.
Péron J, Reverdy T, Smenteck C, Cortet M, You B, Freyer G. Péron J, et al. Among authors: reverdy t. Cancers (Basel). 2021 Jun 2;13(11):2757. doi: 10.3390/cancers13112757. Cancers (Basel). 2021. PMID: 34199352 Free PMC article.
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.
Bruyère CL, Souquet PJ, Dalle S, Corbaux P, Boespflug A, Duruisseaux M, Kiakouama-Maleka L, Reverdy T, Maugeais M, Sahin G, Maillet D, Péron J. Bruyère CL, et al. Among authors: reverdy t. Cancers (Basel). 2021 May 14;13(10):2365. doi: 10.3390/cancers13102365. Cancers (Basel). 2021. PMID: 34068892 Free PMC article.
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study.
Maugeais M, Péron J, Dalle S, Boespflug A, Duruissaux M, Corbaux P, Reverdy T, Sahin G, Rabier A, Lopez J, Freymond N, Maillet D. Maugeais M, et al. Among authors: reverdy t. Biomedicines. 2022 Dec 29;11(1):83. doi: 10.3390/biomedicines11010083. Biomedicines. 2022. PMID: 36672591 Free PMC article.
18 results